0001582945-17-000001.txt : 20170131 0001582945-17-000001.hdr.sgml : 20170131 20170130175700 ACCESSION NUMBER: 0001582945-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170131 DATE AS OF CHANGE: 20170130 EFFECTIVENESS DATE: 20170131 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AIT Therapeutics, Inc. CENTRAL INDEX KEY: 0001641631 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 473812456 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-279637 FILM NUMBER: 17558722 BUSINESS ADDRESS: STREET 1: 2 DERECH MEIR WEISGAL CITY: REHOVOT STATE: L3 ZIP: 763205 BUSINESS PHONE: 972-8-684-3313 MAIL ADDRESS: STREET 1: 2 DERECH MEIR WEISGAL CITY: REHOVOT STATE: L3 ZIP: 763205 FORMER COMPANY: FORMER CONFORMED NAME: KokiCare, Inc. DATE OF NAME CHANGE: 20150507 D 1 primary_doc.xml X0707 D LIVE 0001641631 AIT Therapeutics, Inc. 2 DERECH MEIR WEISGAL REHOVOT L3 ISRAEL 763205 972-8-684-3313 DELAWARE KokiCare, Inc. Corporation true 2015 Ron Bentsur 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Amir Avniel 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Executive Officer Director Yossef Av-Gay 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Racheli Vizman 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Executive Officer David Grossman 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Ari Raved 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Jerome B. Zeldis 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Steven A. Lisi 2 Derech Meir Weisgal Rehovot L3 ISRAEL 763205 Director Pharmaceuticals Decline to Disclose 06b false 2017-01-13 false true true true Shares of common stock issued in exchange for the cancellation of equity of Advanced Inhalation Therapies (AIT) Ltd. upon closing of a reverse merger transaction with such entity. 0 36978258 36978258 0 Offering amount derived from value of Advanced Inhalation Therapies (AIT) Ltd Ordinary Shares cancelled in exchange for shares of Issuer's common stock. The common stock was issued in a share exchange transaction with no additional consideration. true 15 58 0 0 0 No new proceeds received in share exchange transaction. false AIT Therapeutics, Inc. Amir Avniel Amir Avniel Chief Executive Officer 2017-01-27